Ameriprise
XBIT icon

Ameriprise’s XBiotech XBIT Stock Holding History

Ameriprise’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-186,796
Closed -$446K – 4231
2025
Q4 		$446K Buy
+186,796
New +$461K ﹤0.01% 3668

Other funds holding XBIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise's XBIT Position: Q1 2026 in Review

Ameriprise sold out of XBiotech (XBIT) in Q1 2026, closing a stake of 186,796 shares — an estimated $446K sold.

Ameriprise first reported a position in XBIT in Q4 2025 and held it in 1 quarter. The position peaked at $446K in Q4 2025. 37 funds tracked by Wall St. Rank hold XBIT as of Q1 2026.

  • Ameriprise reported no remaining XBiotech position as of Q1 2026 after selling out during the quarter.
  • Ameriprise sold 186,796 XBiotech shares in Q1 2026, an estimated $446K.
  • Ameriprise first reported a position in XBiotech in Q4 2025 and held it in 1 quarter.
  • Ameriprise's XBiotech position peaked at $446K in Q4 2025.
  • 37 funds tracked by Wall St. Rank held XBiotech as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.